Across TCGA cell cohorts, OR6C65 mutation is significantly associated with the mutation status of many other genes, with 429 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible OR6C65-associated genes across cancer lineages are EPHX3, CDH23, and PCDH10. Each is linked with OR6C65 in more than 2 cancer types. Because this analysis shows association rather than direction, both OR6C65-to-partner and partner-to-OR6C65 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR6C65→partner) and Y-score (partner→OR6C65) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LARGE_INTESTINE	EPHX3 →	+5.087	+4.523	.006	.006	1	3
LUNG_NSCLC_LUSC	CDH23 →	+3.938	+3.263	.002	.002	1	2
LUNG_NSCLC_LUSC	PCDH10 →	+3.260	+3.974	<.001	<.001	1	2
LUNG_NSCLC_LUSC	AHCTF1 →	+2.260	+3.473	.005	.005	1	2
LUNG_NSCLC_LUSC	BSN →	+2.260	+3.473	.005	.005	1	2
LUNG_NSCLC_LUSC	LMBRD1 →	+3.938	+3.263	.002	.002	1	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 429 associations by consensus.

Exploration

OR6C65 survival (RNA) · tumor vs normal (RNA) · all OR6C65 data types